Lv1
40 积分 2023-06-08 加入
First-in-Human Phase 1 study of a CD16A bispecific innate cell engager, AFM24, targeting EGFR-expressing solid tumors
12小时前
已完结
Hallmarks of Cancer: New Dimensions
2个月前
已完结
Hallmarks of Cancer: The Next Generation
2个月前
已完结
The Hallmarks of Cancer
2个月前
已完结
Human autoimmune diseases: a comprehensive update
3个月前
已完结
Considerations for Single-Arm Trials to Support Accelerated Approval of Oncology Drugs
3个月前
已关闭
Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000–19: a retrospective, cross-sectional, population-based study
10个月前
已完结
Regulatory Affairs in the Pharmaceutical Industry
10个月前
已完结
Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers
10个月前
已完结
Stability and degradation products of imipenem applying High‐Resolution Mass Spectrometry: an analytical study focused on solutions for infusion
1年前
已完结
皖公网安备34019202002308
